Ypsomed Holding AG (SWX:YPSN)

Market Cap	5.35B
Revenue (ttm)	748.87M
Net Income (ttm)	87.50M
Shares Out	13.65M
EPS (ttm)	6.41
PE Ratio	61.15
Forward PE	26.24
Dividend	2.20 (0.56%)
Ex-Dividend Date	Jul 4, 2025

Volume	19,749
Average Volume	11,654
Open	399.50
Previous Close	392.00
Day's Range	387.50 - 406.50
52-Week Range	261.00 - 441.50
Beta	1.18
RSI	45.38
Earnings Date	Nov 12, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,644
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In 2024, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.